Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors.

• Authors : Kühne JF; Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany.; Neudörfl C

• Source: Transplant immunology [Transpl Immunol] 2020 Aug; Vol. 61, pp. 101291. Date of Electronic Publication: 2020 Apr 21.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

B cells latently infected with murine gammaherpesvirus 68 (MHV-68) are present in the mouse thymus-A step toward immune evasion?

• Authors : Yamano T; Institute for Immunology, Ludwig-Maximilians-University Munich, Munich, Germany.; Steinert M

Subjects: Immune Evasion* ; Immune Tolerance*; B-Lymphocytes/B-Lymphocytes/B-Lymphocytes/*immunology

• Source: European journal of immunology [Eur J Immunol] 2019 Feb; Vol. 49 (2), pp. 351-352. Date of Electronic Publication: 2018 Dec 10.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141

Record details

Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL.

• Authors : Liu WH; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Marchioninistraße 25, 81377 Munich, Germany.; Mrozek-Gorska P

• Source: Biomarker research [Biomark Res] 2020 Sep 16; Vol. 8, pp. 46. Date of Electronic Publication: 2020 Sep 16 (Print Publication: 2020).Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: eCollection Cited Medium: Print ISSN: 2050-7771

Record details

CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease.

• Authors : Slabik C; Laboratory of Regenerative Immune Therapies Applied, Hannover Medical School, 30625 Hannover, Germany.; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.

• Source: Molecular therapy oncolytics [Mol Ther Oncolytics] 2020 Aug 08; Vol. 18, pp. 504-524. Date of Electronic Publication: 2020 Aug 08 (Print Publication: 2020).Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705

Record details

CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease

• Authors : Slabik, C.^1,2,3; Kalbarczyk, M.^1,2,3; Danisch, S.^1,2,3

• Source: In: Molecular Therapy - Oncolytics. (Molecular Therapy - Oncolytics, 25 September 2020, 18:504-524)

Record details

Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL

• Authors : Liu, W.-H.¹; Wirth, A.-K.¹; Herold, T.^1,3

• Source: In: Biomarker Research. (Biomarker Research, 16 September 2020, 8(1))

Record details

Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors

• Authors : Kühne, J.F.¹; Neudörfl, C.¹; Beushausen, K.¹

• Source: In: Transplant Immunology. (Transplant Immunology, August 2020, 61)

Record details

Epigenetic lifestyle of Epstein-Barr virus.

• Authors : Buschle A; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Centre for Infection Research (DZIF), Partner site Munich, Marchioninistr. 25, D-81377, Munich, Germany.; Hammerschmidt W

• Source: Seminars in immunopathology [Semin Immunopathol] 2020 Apr; Vol. 42 (2), pp. 131-142. Date of Electronic Publication: 2020 Mar 30.Publisher: Springer Country of Publication: Germany NLM ID: 101308769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1863-2300

Record details

First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.

• Authors : Pich D; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Center for Infection Research (DZIF), Munich, Germany.; Mrozek-Gorska P

Subjects: Cell Proliferation* ; Herpesvirus 4, Human*; B-Lymphocytes/B-Lymphocytes/B-Lymphocytes/*immunology

• Source: MBio [mBio] 2019 Sep 17; Vol. 10 (5). Date of Electronic Publication: 2019 Sep 17.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Electronic Cited Medium:

Record details

Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.

• Authors : Mrozek-Gorska P; Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Center for Infection Research, D-81377 Munich, Germany.; Buschle A

Subjects: B-Lymphocytes/B-Lymphocytes/B-Lymphocytes/*virology ; Epstein-Barr Virus Infections/Epstein-Barr Virus Infections/Epstein-Barr Virus Infections/*virology ; Herpesvirus 4, Human/Herpesvirus 4, Human/Herpesvirus 4, Human/*physiology

• Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Aug 06; Vol. 116 (32), pp. 16046-16055. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details